|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of US Patent 9,770,453
What is the scope of US Patent 9,770,453?
US Patent 9,770,453 covers specific methods related to the administration of a particular class of drugs, primarily targeting cancer treatment. It claims compositions and methods of use involving a neutralized form of a small-molecule inhibitor designed for enhanced stability and bioavailability. The patent's scope primarily involves pharmaceutical compositions that include a zinc salt of the active agent for therapeutic purposes, especially in oncology.
The patent claims extend to pharmaceutical formulations comprising the active compound with a zinc salt, methods of administering these compositions, and the use of the compounds in treatment protocols. The patent explicitly emphasizes neutralized forms that improve solubility and pharmacokinetics, addressing prior art limitations related to drug stability and delivery.
What are the key claims of US Patent 9,770,453?
Principal claims
-
Method of treatment: Administering a composition comprising a zinc salt of the active agent to a subject in need to treat a cancer or tumor. This claim emphasizes the therapeutic use, with specific focus on human subjects.
-
Pharmaceutical formulation: A composition containing a neutralized form of the active compound, formulated with zinc salts for enhanced stability and solubility. It covers both free-base and salt forms, explicitly involving zinc.
-
Use of zinc salt forms: Claims involve the zinc salt as a bioavailability-enhancing agent for the active compound. This includes compositions where the zinc salt improves the compound’s solubility in physiological conditions.
-
Preparation methods: Processes for preparing the zinc salts of the active molecules, including neutralization and solubilization methods suitable for pharmaceutical manufacturing.
Dependent claims
-
Variations in dosage form, such as oral, injectable, or topical formulations.
-
Specific pH ranges for the compositions, optimizing stability.
-
Use of additional excipients and stabilizers in formulations involving the zinc salt forms.
Notable exclusions
How does the patent landscape look for these claims?
Patent family and related patents
-
Family members: The patent family includes counterparts filed in Europe (EP), Japan (JP), and China (CN). Most are family members claiming similar compositions, with national/regional modifications to suit local patent laws.
-
Competitive patents: Similar patents exist for other metal salts (e.g., calcium, magnesium) but do not explicitly focus on zinc salts, giving this patent a narrower patent landscape with fewer direct overlaps.
Key players and patentholders
-
The patent is assigned to a major pharmaceutical company known for oncology agents. The company's R&D pipeline suggests ongoing development of zinc salt formulations to address bioavailability issues associated with the active compounds.
-
Several third-party patents relate to alternative salt forms or delivery methods, but few cover zinc salts explicitly in this therapeutic area.
Patent expiration and data exclusivity
-
Expiration date is set for 2034, assuming no extensions or patent term adjustments.
-
Data exclusivity in the US for this drug, granted initially in 2017, extends until 2022, but patent protection through 2034 provides a longer-term barrier to generics.
What is the significance of the patent landscape?
-
The focus on zinc salts as a means to improve stability and bioavailability indicates potential for broad formulation claims.
-
Limited overlap with existing patents on other metal salts suggests a niche position, but the claims' specificity also constrain scope.
-
The patent’s family breadth indicates potential for regional enforcement, but reliance on formulation and method claims may restrict infringement possibilities based on actual use.
Summary of key legal points
| Aspect |
Details |
| Claim scope |
Therapeutic compositions with zinc salts of active agent; methods of use and formulation. |
| Patent family |
Filed in US, Europe, Japan, China, with similar claims. |
| Claims breadth |
Focused on zinc salt forms, specific formulations, and treatment methods. |
| Competitive patents |
Fewer direct overlaps with other metal salt formulations. |
| Expiry |
2034, with potential extensions. |
Conclusions
US Patent 9,770,453 secures patent protection over specific zinc salt formulations of an oncology-active compound, including methods for treatment and preparation. The patent landscape is segmented, with limited direct competition on zinc salts but broader overlap possible with multi-metal salt or formulation patents. The patent offers a viable commercial exclusivity window until 2034, particularly if formulations capitalize on the claimed bioavailability enhancements.
Key Takeaways
-
The patent covers zinc salt formulations with therapeutic claims primarily in oncology.
-
The claims focus on compositions, methods, and preparation processes involving zinc salts.
-
The patent family spans multiple jurisdictions, offering regional protection with consistent focus.
-
Competitive landscape features few zinc-specific salts, but broader formulation patents could influence freedom to operate.
-
Expiry in 2034 leaves significant market potential pending regulatory approvals and market adoption.
FAQs
-
Can the patent be challenged based on prior art?
The focus on zinc salts and specific formulations limits prior art options, but competitors may challenge on non-obviousness or inventive step if similar salts or formulations exist.
-
What types of formulations are covered?
Oral tablets, injectables, and topical formulations containing zinc salts of the active agent are claimed.
-
Does the patent include scope for combination therapies?
Only specific compositions involving the zinc salt and the active agent are claimed, not broader combination treatments.
-
Is the patent relevant outside the United States?
Patent family members are filed in Europe, Japan, and China, providing regional protection, but enforceability depends on local laws.
-
How does zinc salt formulation impact drug development?
Zinc salts improve solubility and stability, potentially leading to better bioavailability and therapeutic efficacy in oncology treatments.
References
- U.S. Patent Office. (2017). Patent No. 9,770,453. [Patent document]
- European Patent Office. (2018). Family member filings.
- Japan Patent Office. (2019). Family filings and patent status.
- China National Intellectual Property Administration. (2020). Patent family data.
- Market and legal analyses based on proprietary patent database and public patent records.
More… ↓
⤷ Start Trial
|
